These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10228500)

  • 1. Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancer.
    Lorusso V; Mancarella S; Catino A; Brandi M; Paradiso A; Latorre A; Mastria A; De Mitrio A; Guida M; De Lena M
    Tumori; 1999; 85(1):60-4. PubMed ID: 10228500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.
    Hainsworth JD
    Ann Oncol; 1993; 4 Suppl 2():37-40. PubMed ID: 7688982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.
    Repetto L; Miglietta L; Gardin G; Lanfranco C; Naso C; Merlini L; Giudici S; Venturino A; Campora E; Testore F
    Breast Cancer Res Treat; 1994; 30(2):133-7. PubMed ID: 7949211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin.
    Venturino A; Comandini D; Simoni C; Merlini L; Naso C; Palumbo R; Fusco V; Porcile G; Pronzato P; Rosso R; Repetto L
    Breast Cancer Res Treat; 2000 Apr; 60(3):195-200. PubMed ID: 10930106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer.
    Colleoni M; Nelli P; Gaion F; Sgarbossa G; Manente P
    Oncology; 1995; 52(6):435-8. PubMed ID: 7478426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: a phase II study.
    Susnjar S; Vasović S; Nesković-Konstantinović Z; Stamatović L; Lukić V; Colaković S; Mitrovic L; Jelić S; Radulović S
    Tumori; 1999; 85(6):478-82. PubMed ID: 10774569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
    Greco FA; Hainsworth JD
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients.
    Bascioni R; Giorgi F; Silva RR; Acito L; Giustini L; De Signoribus G; Giuliodori L; Testa E
    Breast Cancer Res Treat; 1997 Sep; 45(3):205-10. PubMed ID: 9386863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity.
    Yen CC; Tung SL; Hsieh RK; Chiou TJ; Liu JH; Wang WS; Chen PM
    Jpn J Clin Oncol; 1997 Oct; 27(5):316-20. PubMed ID: 9390208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage chemotherapy in metastatic breast cancer: an experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorin.
    Colozza M; Gori S; Mosconi AM; Anastasi P; Basurto C; Ludovini V; De Angelis V; Giansanti M; Tonato M
    Breast Cancer Res Treat; 1996; 38(3):277-82. PubMed ID: 8739080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.
    Hainsworth JD; Jones SE; Mennel RG; Blum JL; Greco FA
    J Clin Oncol; 1996 May; 14(5):1611-6. PubMed ID: 8622079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and well-tolerated regimen for the treatment of advanced breast cancer.
    Wils JA
    Eur J Cancer; 1993; 29A(15):2106-8. PubMed ID: 8297648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone, 5-fluorouracil and high-dose leucovorin (NFL) in the treatment of metastatic breast cancer: randomized comparison to cyclophosphamide, methotrexate and 5-fluorouracil (CMF) and attempts to improve efficacy by adding paclitaxel.
    Hainsworth JD
    Eur J Cancer Care (Engl); 1997 Dec; 6(4 Suppl):4-9. PubMed ID: 9460336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of mitoxantrone plus cyclophosphamide and 5-fluorouracil in modulation with levo-folinate for advanced breast cancer patients.
    Leonardi V; Meli M; Palmeri S; Russo A; Rini GB; Peralta S; Rausa L
    J Chemother; 1995 Apr; 7(2):160-6. PubMed ID: 7545224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer.
    Hainsworth JD; Andrews MB; Johnson DH; Greco FA
    J Clin Oncol; 1991 Oct; 9(10):1731-5. PubMed ID: 1919624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients.
    Mammoliti S; Merlini L; Caroti C; Gallo L
    Breast Cancer Res Treat; 1996; 37(1):93-6. PubMed ID: 8750532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer.
    Jones SE; Mennel RG; Brooks B; Westrick MA; Allison MA; Paulson RS; Tilmann K; Rea B
    J Clin Oncol; 1991 Oct; 9(10):1736-9. PubMed ID: 1919625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
    Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
    Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of 5-fluorouracil and high-dose folinic acid in combination with cyclophosphamide and mitoxantrone for advanced breast cancer.
    Aitini E; Cavazzini G; Cantore M; Rabbi C; Rivera A; Togliani B; Di Marco A; Smerieri F
    Eur J Cancer; 1992; 28A(12):1968-70. PubMed ID: 1419291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.